A recent federal court ruling that attempted to set down a distinct line between marijuana and low-THC products (like CBD and delta-8) has led many to make broad conclusions as to what it means for various products. Courts...more
Newsworthy Highlights -
Company to Expand Clinical Trial of Cannabis Therapy for Tourette Syndrome. A pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system...more
Newsworthy Highlights -
Supreme Court Refuses to Hear Medical Cannabis Workers’ Compensation Case. On June 21, 2022, the U.S. Supreme Court denied two petitions for a writ of certiorari brought by injured workers in...more
Newsworthy Highlights -
FDA Continues CBD Warnings; Sends Letters to Companies Selling CBD Products for Food-Producing Animals. On May 26, 2022, the U.S. Food and Drug Administration (FDA) issued warning letters to four...more
Newsworthy Highlights -
FDA Warns Companies Selling Delta-8 Products. On May 4, 2022, the U.S. Food and Drug Administration issued warning letters to five companies for selling products labeled as containing delta-8...more
Newsworthy Highlights -
MORE Act Passes House Again. On April 1, 2022, the U.S. House of Representatives again passed the Marijuana Opportunity Reinvestment and Expungement Act (the MORE Act), a proposed piece of federal...more
The Ohio Medical Marijuana Control Program (MMCP) recently filed proposed rule updates with the Joint Committee on Agency Rule Review to begin the legislature's rule-review process.
MMCP will conduct a public hearing...more
Newsworthy Highlights -
Oregon Landowners Cautioned About Leasing Property for Illegal Cannabis Cultivation. Landowners in Jackson County, Oregon, were advised to do their due diligence when leasing their property for...more
Newsworthy Highlights -
Cannabis Company Contests $166K Cash Seizure by Kansas Police. According to news articles, Kansas police seized $166,000 in Missouri medical marijuana profits during a traffic stop, claiming the...more
Newsworthy Highlights -
FDA and CDC Issue Warnings on Delta-8 Use. In response to a marked uptick in reported adverse reactions and hospitalizations, the U.S. Food and Drug Administration (FDA ) and the Centers for Disease...more
Newsworthy Highlights -
• The National Institute of Standards and Technology published a 196-page report from the Cannabis Quality Assurance Program analyzing cannabis testing labs quantification of CBD and THC. The...more
In episode 9 of McGuireWoods' Edible Bites video webinar series, healthcare attorneys Kate Hardey, Royce DuBiner and Janice Suchyta discuss issues pertaining to cannabis and privacy laws, such as HIPAA and the California...more
8/12/2021
/ California Consumer Privacy Act (CCPA) ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Consumer Information ,
Consumer Privacy Rights ,
Data Breach ,
Data Privacy ,
Data Protection ,
Dispensaries ,
Duty to Protect ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Marijuana ,
Medical Marijuana ,
Privacy Laws ,
Recreational Use ,
State Privacy Laws
While most cannabidiol (CBD) manufacturers and sellers focus on the U.S. Food and Drug Administration (FDA), federal agencies outside the FDA have put their focus on the CBD industry....more
Cannabidiol (CBD) products increasingly are showing up in the mainstream market and taking many forms, including CBD-infused beverages, chocolates, and even beauty products. CBD, a plant-based compound naturally occurring in...more